Cumberland Pharmaceuticals Inc. (CPIX) vs Organigram Global Inc. (OGI)
- Cumberland Pharmaceuticals Inc. CPIX 7.18 −4.77%
- Organigram Global Inc. OGI 0.93 0.00%
Cumberland Pharmaceuticals Inc. and Organigram Global Inc. are both Drug Manufacturers Specialty & Generic companies. Organigram Global Inc. is the larger, with a market value of $131.4M against $113.0M — 1.2× the size. Cumberland Pharmaceuticals Inc. has negative trailing earnings, so its P/E is not meaningful; Organigram Global Inc. trades at 2.0×. Organigram Global Inc. grew revenue faster over the last twelve months: 39.5% against 32.0%. Organigram Global Inc. has the higher net margin (28.4% vs −26.2%) and the higher return on invested capital (−1.53% vs −34.2%). Across the 18 metrics below, Organigram Global Inc. leads on 14 and Cumberland Pharmaceuticals Inc. on 4.
Valuation
Profitability
| Metric | CPIX | OGI | Drug Manufacturers Specialty & Generic median |
|---|---|---|---|
| Gross margin | 82.80% | 36.47% | 53.94% |
| Operating margin | (17.39%) | (3.91%) | 0.00% |
| Net margin | (26.17%) | 28.44% | 0.00% |
| Free cash flow margin | 1.38% | (9.46%) | 0.00% |
| Return on equity | (48.76%) | 20.20% | (0.40%) |
| Return on assets | (16.70%) | 12.70% | (3.32%) |
| Return on invested capital | (34.23%) | (1.53%) | 0.00% |
Growth
Health
Dividend
Size
Any metric, up to five companies and an Excel export Powerpack